Loss-to-follow-up and follow-up rates of cohort analysis patients
| NCD cohort | LTFU* | Facility (MLP) | Community (CHW) | Combined | ||
| Follow-up visits | Days between last two visits | Follow-up visits | Days between last two visits | Monthly touch-points per patient | ||
| (%) | Median (Q1,Q3) | Median (Q1,Q3) | Median (Q1,Q3) | Median (Q1,Q3) | Median (Q1,Q3) | |
| Diabetes | 16 | 6 (44, 8) | 67 (38, 126) | 10 (44, 13) | 29 (2121, 41) | 0.9 (0.5, 1.2) |
| Hypertension | 19 | 6 (44, 9) | 62 (36, 111) | 10 (55, 13) | 30 (2525, 42) | 0.9 (0.6, 1.2) |
| COPD | 22 | 7 (44, 9) | 56 (34, 98) | 11 (66, 14) | 30 (2626, 39) | 0.9 (0.7, 1.3) |
*A patient was defined as LTFU if they never had a follow-up visit at the facility. These patients were excluded from the analysis cohort.
CHW, community health worker; COPD, chronic obstructive pulmonary disease; LTFU, lost to follow-up; MLP, mid-level practitioner; NCD, non-communicable disease.